Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears ResMed's OSA (obstructive sleep apnoea) product platform:

This article was originally published in Clinica

Executive Summary

ResMed has received US FDA 510(k) clearance to market its S7 Elite CPAP and AutoSet Spirit autotitrating devices for treating obstructive sleep apnoea (OSA). Both systems offer fully integrated heated humidification options and use system hardware common to both units, allowing accessories to be added or interchanged between models and ultimately streamlining inventory management, says the San Diego, California firm. The integrated devices are smaller and quieter than ResMed's current product line.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT067521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel